Clinical Trials Logo

Stress Disorders, Traumatic clinical trials

View clinical trials related to Stress Disorders, Traumatic.

Filter by:

NCT ID: NCT03421587 Completed - Clinical trials for Post-traumatic Stress Disorder

Perception of Stressful Social Stimuli After Trauma Exposure.

Start date: November 2015
Phase:
Study type: Observational

Post-traumatic stress disorder is associated with altered processing of sensory stimuli. The clinical phenotype PTSD has predominantly been described for the visual and auditory sensory modalities. However, PTSD symptoms such as intrusive memories are often evoked by olfactory and tactile cues in the environment. Moreover, little is known about whether aberrant responses to social olfactory and tactile stimuli are also present in a subclinical population.The purpose of this study is to compare trauma-exposed subjects (e.g. childhood maltreatment) with non-exposed controls in the processing of olfactory and tactile stimuli. This sensory characterizations hold potential to identify potential biomarkers for the course of trauma-related disorders and to inform trauma therapies focusing on sensory integration.

NCT ID: NCT03400813 Completed - Clinical trials for Post-Traumatic Stress Disorder

Eye-Movement Desensitization and Post-Traumatic Syndroms

SOFTER3
Start date: January 15, 2018
Phase: N/A
Study type: Interventional

Millions people, all over the world, are admitted in the Emergency Department after a trauma or simply to receive medical cares. In France, it represents 10 million patients. Probably because of stress associated with the event, 20% will suffer a combination of non-specifics symptoms which persist for many months and with daily life quality impairment. The investigators hypothesize that an early intervention, such as Eye-Movement, Desensitization and Reprocessing (EMDR) could be performed in the ED and could prevent the occurrence of these symptoms.

NCT ID: NCT03384706 Completed - Clinical trials for Posttraumatic Stress Disorder

A Comparison of CPT Versus ART Versus WL

Start date: September 6, 2017
Phase: N/A
Study type: Interventional

The purpose of this research study is to compare the effectiveness of two treatments for the symptoms of Posttraumatic Stress Disorder (PTSD) with a no therapy, wait-list control condition. The two treatments are Cognitive Processing Therapy (CPT) as compared to Accelerated Resolution Therapy (ART). Both have been found to be effective with veterans and civilians in prior studies but they have never been compared to one another. Participants will be 280 males and females ages 18 and older who meet criteria for PTSD (or subthreshold PTSD). PTSD is a condition that can occur after a trauma experience such as combat, sexual abuse, physical abuse, or natural disasters.

NCT ID: NCT03376633 Completed - Depression Clinical Trials

The Impact of a School-Based, Trauma-Informed CBT Intervention for Young Women

Start date: October 1, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is: 1. To conduct a randomized controlled trial to evaluate the impact of Working on Womanhood (WOW), a school-based, trauma-informed counseling and clinical mentoring program for young women in Chicago, on PTSD, anxiety, depression. In addition, this study will examine the effect of WOW on other, secondary outcomes such as school discipline, GPA, high school graduation, and criminal justice involvement, risky behaviors, and other social-emotional learning outcomes. 2. To evaluate the cost-effectiveness of the WOW program.

NCT ID: NCT03375294 Completed - Clinical trials for Post Traumatic Stress Disorder

Exploring Nitrous Oxide Effects for Post Traumatic Stress Disorder (PTSD)

tN2O
Start date: April 1, 2018
Phase: Phase 2
Study type: Interventional

The purpose of this study is to understand nitrous oxide effects in post traumatic stress disorder (PTSD)

NCT ID: NCT03372460 Completed - Clinical trials for Post-Traumatic Stress Disorder

tDCS Plus Virtual Reality for PTSD

TAVRE
Start date: April 2, 2018
Phase: N/A
Study type: Interventional

This study will test the effectiveness of combining non-invasive brain stimulation, called transcranial direct current stimulation (tDCS), with virtual reality exposure as a treatment for Veterans with chronic posttraumatic stress disorder (PTSD). Investigators will test whether this intervention improves PTSD symptoms and improves quality of life. Results from this study may be used to develop a new non-medication approach to treating chronic PTSD.

NCT ID: NCT03367533 Completed - Bipolar Disorder Clinical Trials

Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response

Start date: November 29, 2018
Phase: Phase 1
Study type: Interventional

The proposed study will assess the combined effect of perampanel and ketamine on the anti-depressant response in individuals with treatment resistant depression. The purpose of this study is to test the hypothesis that stimulation of Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid receptors (AMPAR) is critical to the anti-depressant response of ketamine.

NCT ID: NCT03352011 Completed - Clinical trials for Post-traumatic Stress Disorder

Primary Care Brief Mindfulness Training for Veterans With PTSD

Start date: January 2, 2018
Phase: N/A
Study type: Interventional

The proposed study supports a line of research that seeks to improve the health of military veterans with post-traumatic stress disorder (PTSD) by teaching them mindfulness skills. The proposed study first gathers Veteran's Affairs mental health provider and peer support specialist feedback to adapt a brief mindfulness intervention and then investigates the feasibility of testing this intervention in a small randomized clinical trial. The study targets primary care patients with PTSD who may be reluctant to engage in other mental health treatments and provides them with mindfulness training to reduce PTSD symptoms, improve psychosocial functioning and increase hope for recovery.

NCT ID: NCT03344471 Completed - Preterm Delivery Clinical Trials

Factors Associated With Post-Traumatic Stress Disorder in Patients With After Preterm Delivery

PTSD-preterm
Start date: December 13, 2017
Phase: N/A
Study type: Interventional

Each year in France, between 50,000 and 60,000 children are born prematurely (< 37 weeks of amenorrhea). Literature has shown that preterm deliveries can be associated with the development of PTSD (Post-Traumatic Stress Disorder) in mothers. Around ¼ of women suffer from a PTSD after giving birth prematurely. Moreover, studies highlighted the consequences of a PTSD on the child-mother relationship. Beyond the importance of early detection, it could be important to predict factors that make women more likely to develop a PTSD. This study will focus on personal factors (5 dimensions of personality). Our hypothesis is that personality traits are associated with the likeliness of developing a PTSD after a preterm delivery.

NCT ID: NCT03337750 Completed - Clinical trials for Posttraumatic Stress Disorder

An Open-Trial of Web-Prolonged Exposure (Web-PE) Among Active-Duty Military

Start date: February 12, 2018
Phase: N/A
Study type: Interventional

It is urgent to make evidence-based treatments (EBTs) for military personnel readily accessible in order to meet the growing demand for effective and efficient treatment for posttraumatic stress disorder (PTSD) in a timely manner. Effective EBTs for PTSD are available, but barriers to accessing care can deter military personnel from receiving treatment. Web-treatments represent an innovative way to overcome these barriers. The efficacy of previously developed web-treatments for PTSD appear promising, however, they are not based on treatment protocols with strong empirical support for their efficacy. No study to date has examined web-treatment of PTSD using a well-established treatment program. The purpose of this open trial is to examine the efficacy of 10 sessions of a web-version of Prolonged Exposure (PE), "Web-PE," delivered over 8-weeks in 40 active-duty military personnel and veterans with PTSD who deployed post 9-11. Up to 60 individuals will be consented to obtain data from 40 for analysis. Participants will be assessed at pre-treatment and 1- and 3-months after treatment completion.